Synamtix

Synamatix is a pioneering bioinformatics and biotechnology company that leverages advanced artificial intelligence and neural network technologies for genomic analysis and drug discovery. Originally recognized for its proprietary SynaBASE platform, which set benchmarks in high-performance pattern detection for genomic data, the company has transitioned its focus toward the development of clinically validated nutraceuticals and botanical drugs. By bridging traditional botanical knowledge with modern pharmaceutical precision, Synamatix aims to accelerate the identification of bioactive compounds to provide safer, natural alternatives to synthetic medicines. The company operates as part of the Neuramatix group, utilizing deep learning to optimize the efficacy and safety profiles of its natural product candidates.